Abbott Laboratories 2013 Annual Report Download - page 29

Download and view the complete annual report

Please find page 29 of the 2013 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 76

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76

27
ABBOTT 2013 ANNUAL REPORT
Abbott’s global presence in branded-generic
pharmaceuticals is strong and growing
• Sales in more than 130 countries
• Extensive manufacturing network to ensure
reliable local supply
• Six pharmaceutical development sites around
the world
PROJECTED EMERGING-MARKET CONSUMER
SPEND ON PHARMACEUTICALS
2012 2017
$219 billion
$406 billion
(estimated)
The fastest-growing emerging pharmaceutical markets
are expected to almost double by 2017, representing
two thirds of global growth. Their global market share
is expected to increase from 23 percent in 2012 to 33
percent in 2017.
Tailored portfolios let Abbott
leverage our global strength
to address the specific needs
of local markets.